BioMarin Pharmaceutical Inc. (0HNC.L) Stock Price
$54.69 0.4%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
9 -
Technical
5
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on BioMarin Pharmaceutical Inc., AI stock picks, stock alerts and much more.
0HNC.L AI Stock Analysis
AI stock analysis for 0HNC.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like BioMarin Pharmaceutical Inc. (0HNC.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
BioMarin Pharmaceutical Inc. (0HNC.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of BioMarin Pharmaceutical Inc. (0HNC.L), currently trading at $54.69, will... Sign up to access price prediction.
About 0HNC.L
-
BioMarin Pharmaceutical Inc.
-
Symbol
0HNC.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
10.5B
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$385.3 0.8% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$144.1 0.4% |
6 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$8.14 2.8% |
5 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$5.53 3.2% |
5 |
 |
Esperion Therapeutics 0IIM.L |
$2.81 2.2% |
6 |
News
0HNC.L Alternative Data
Web Traffic
BioMarin Pharmaceutical Inc. receives an estimated 74589 monthly visitors to biomarin.com.
-
Web Traffic
74589
-
Change from Previous Month
0.1%
-
3 Month Change
2.5%
-
YoY Change
2.5%
Twitter Followers
BioMarin Pharmaceutical Inc. has 738 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.7% over the last month.
-
Twitter Followers
738
-
Daily Change
0.1%
-
1 Month Change
0.7%
-
3 Month Change
5.4%
-
YoY Change
5.4%
TikTok Followers
BioMarin Pharmaceutical Inc. has 20 Followers on its main TikTok account.
-
TikTok Followers
20
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
25%
-
YoY Change
25%
Facebook Engagement
BioMarin Pharmaceutical Inc. has engaged 4,243 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
4243
-
Daily Change
2.4%
-
1 Month Change
150.9%
-
3 Month Change
67.8%
-
YoY Change
67.8%
Instagram Followers
BioMarin Pharmaceutical Inc. has 5,940 Instagram Followers on its main Instagram account, up by 3% over the last month.
-
Instagram Followers
5940
-
Daily Change
0.2%
-
1 Month Change
3%
-
3 Month Change
6.1%
-
YoY Change
6.1%
Youtube Subscribers
BioMarin Pharmaceutical Inc. has 1,960 subscribers on its main Youtube channel, up by 0.5% over the last month.
-
Youtube Subscribers
1960
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
1%
-
YoY Change
1%
Job Postings
BioMarin Pharmaceutical Inc. currenly has an estimated 131 open job postings, up by 12% over the last month.
-
Job Postings
131
-
Daily Change
0.8%
-
1 Month Change
12%
-
3 Month Change
3.7%
-
YoY Change
3.7%
Reddit Mentions
BioMarin Pharmaceutical Inc. has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
200,905 are following BioMarin Pharmaceutical Inc. on LinkedIn, up by 1.4% over the last month.
-
LinkedIn Followers
200905
-
Daily Change
1.4%
-
1 Month Change
1.4%
-
3 Month Change
4.5%
-
YoY Change
4.5%
App Downloads
-
App Downloads
4000
-
Daily Change
0%
LinkedIn Employees
According to LinkedIn, BioMarin Pharmaceutical Inc. has 3,116 employees, down by -0.3% over the last month.
-
LinkedIn Employees
3116
-
Daily Change
0.3%
-
1 Month Change
0.3%
-
3 Month Change
0.3%
-
YoY Change
0.3%
Business Outlook
According to employee reviews, the business outlook among employees at BioMarin Pharmaceutical Inc. is 34 out of 100 (bearish).
-
Business Outlook
34
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
BioMarin Pharmaceutical Inc. was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0HNC.L Financials
0HNC.L Key Metrics
-
Total Revenue
$745.1M
-
Net Income
$185.7M
-
Earnings per Share
$0.97
-
Free cash flow
$157.6M
-
EBITDA
$223.9M
-
EBITDA Ratio
0.300469
-
Total Assets
$7.1B
0HNC.L 2-year Revenue & Income
0HNC.L 2-year Free Cash Flow
0HNC.L Technicals
0HNC.L SMA
0HNC.L RSI
FAQ
What's the current price of BioMarin Pharmaceutical Inc. (0HNC.L) Stock?
The price of an BioMarin Pharmaceutical Inc. (0HNC.L) share is $54.69.
What's the market cap of BioMarin Pharmaceutical Inc.?
The current market cap of BioMarin Pharmaceutical Inc. is 10.5B.
What are some stocks similar to BioMarin Pharmaceutical Inc. (0HNC.L) that investors often compare it to?
BioMarin Pharmaceutical Inc. (0HNC.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Esperion Therapeutics.
What is the forecast for BioMarin Pharmaceutical Inc.'s stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast BioMarin Pharmaceutical Inc.'s stock price to be around $59.1 in 2026. Starting from the current price of $54.69, this represents a 8.1% change in price, indicating a bullish outlook for the stock.
How to buy BioMarin Pharmaceutical Inc. (0HNC.L) Stock?
BioMarin Pharmaceutical Inc. stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy BioMarin Pharmaceutical Inc. shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.